Gut-brain Axis and Neurodegeneration: Mechanisms and Therapeutic Potentials

Overview

Journal Front Neurosci

Date 2024 Nov 8

PMID 39513042

Authors

Kelly Jimin Park

Yao Gao

Affiliations

Soon will be listed here.

Abstract

This paper reviews the effects of gut microbiota in regulating neurodegenerative diseases through controlling gut-brain axis. Specific microbial populations and their metabolites (short-chain fatty acids and tryptophan derivatives) regulate neuroinflammation, neurogenesis and neural barrier integrity. We then discuss ways by which these insights lead to possible interventions - probiotics, prebiotics, dietary modification, and fecal microbiota transplantation (FMT). We also describe what epidemiological and clinical studies have related certain microbiota profiles with the courses of neurodegenerative diseases and how these impact the establishment of microbiome-based diagnostics and individualized treatment options. We aim to guide microbial ecology research on this key link to neurodegenerative disorders and also to highlight collaborative approaches to manage neurological health by targeting microbiome-related factors.

Citing Articles

The Neonatal Microbiome: Implications for Amyotrophic Lateral Sclerosis and Other Neurodegenerations.

Eisen A, Kiernan M Brain Sci. 2025; 15(2).

PMID: 40002527 PMC: 11852589. DOI: 10.3390/brainsci15020195.

Beyond weight loss: exploring the neurological ramifications of altered gut microbiota post-bariatric surgery.

Almheiri R, Hajjar B, Alkhaaldi S, Rabeh N, Aljoudi S, Abd-Elrahman K J Transl Med. 2025; 23(1):223.

PMID: 39994634 PMC: 11852891. DOI: 10.1186/s12967-025-06201-2.

A Review of the Consequences of Gut Microbiota in Neurodegenerative Disorders and Aging.

Menezes A, Shah Z Brain Sci. 2025; 14(12.

PMID: 39766423 PMC: 11726757. DOI: 10.3390/brainsci14121224.

References

Fock E, Parnova R . Mechanisms of Blood-Brain Barrier Protection by Microbiota-Derived Short-Chain Fatty Acids. Cells. 2023; 12(4). PMC: 9954192. DOI: 10.3390/cells12040657. View

Grasselli J, Elez E, Caratu G, Matito J, Santos C, Macarulla T . Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer. Ann Oncol. 2017; 28(6):1294-1301. PMC: 5834108. DOI: 10.1093/annonc/mdx112. View

Ghezzi L, Cantoni C, Rotondo E, Galimberti D . The Gut Microbiome-Brain Crosstalk in Neurodegenerative Diseases. Biomedicines. 2022; 10(7). PMC: 9312830. DOI: 10.3390/biomedicines10071486. View

Raval U, Harary J, Zeng E, Pasinetti G . The dichotomous role of the gut microbiome in exacerbating and ameliorating neurodegenerative disorders. Expert Rev Neurother. 2020; 20(7):673-686. PMC: 7387222. DOI: 10.1080/14737175.2020.1775585. View

Gohl D, Vangay P, Garbe J, MacLean A, Hauge A, Becker A . Systematic improvement of amplicon marker gene methods for increased accuracy in microbiome studies. Nat Biotechnol. 2016; 34(9):942-9. DOI: 10.1038/nbt.3601. View

Wang Q, Luo Y, Chaudhuri K, Reynolds R, Tan E, Pettersson S . The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options. Brain. 2021; 144(9):2571-2593. DOI: 10.1093/brain/awab156. View

Freiwald A, Sauer S . Phylogenetic classification and identification of bacteria by mass spectrometry. Nat Protoc. 2009; 4(5):732-42. DOI: 10.1038/nprot.2009.37. View

Dugger B, Dickson D . Pathology of Neurodegenerative Diseases. Cold Spring Harb Perspect Biol. 2017; 9(7). PMC: 5495060. DOI: 10.1101/cshperspect.a028035. View

Riccio P, Rossano R . Undigested Food and Gut Microbiota May Cooperate in the Pathogenesis of Neuroinflammatory Diseases: A Matter of Barriers and a Proposal on the Origin of Organ Specificity. Nutrients. 2019; 11(11). PMC: 6893834. DOI: 10.3390/nu11112714. View

10.

Onyango I, Bennett J, Stokin G . Regulation of neuronal bioenergetics as a therapeutic strategy in neurodegenerative diseases. Neural Regen Res. 2021; 16(8):1467-1482. PMC: 8323696. DOI: 10.4103/1673-5374.303007. View

11.

Lin Z, Ma X . Dietary nutrients mediate crosstalk between bile acids and gut microbes in animal host metabolism. Crit Rev Food Sci Nutr. 2022; 63(28):9315-9329. DOI: 10.1080/10408398.2022.2067118. View

12.

Zhu G, Zhao J, Zhang H, Chen W, Wang G . Probiotics for Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Meta-Analysis. Foods. 2021; 10(7). PMC: 8303183. DOI: 10.3390/foods10071672. View

13.

Braniste V, Al-Asmakh M, Kowal C, Anuar F, Abbaspour A, Toth M . The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med. 2014; 6(263):263ra158. PMC: 4396848. DOI: 10.1126/scitranslmed.3009759. View

14.

Bertram L, Tanzi R . The genetic epidemiology of neurodegenerative disease. J Clin Invest. 2005; 115(6):1449-57. PMC: 1137006. DOI: 10.1172/JCI24761. View

15.

Kang J, Zivkovic A . The Potential Utility of Prebiotics to Modulate Alzheimer's Disease: A Review of the Evidence. Microorganisms. 2021; 9(11). PMC: 8625457. DOI: 10.3390/microorganisms9112310. View

16.

Mahmoudiandehkordi S, Arnold M, Nho K, Ahmad S, Jia W, Xie G . Altered bile acid profile associates with cognitive impairment in Alzheimer's disease-An emerging role for gut microbiome. Alzheimers Dement. 2018; 15(1):76-92. PMC: 6487485. DOI: 10.1016/j.jalz.2018.07.217. View

17.

Maitre M, Klein C, Patte-Mensah C, Mensah-Nyagan A . Tryptophan metabolites modify brain Aβ peptide degradation: A role in Alzheimer's disease?. Prog Neurobiol. 2020; 190:101800. DOI: 10.1016/j.pneurobio.2020.101800. View

18.

Tang W, Zhu H, Feng Y, Guo R, Wan D . The Impact of Gut Microbiota Disorders on the Blood-Brain Barrier. Infect Drug Resist. 2020; 13:3351-3363. PMC: 7532923. DOI: 10.2147/IDR.S254403. View

19.

Liu J, Li H, Gong T, Chen W, Mao S, Kong Y . Anti-neuroinflammatory Effect of Short-Chain Fatty Acid Acetate against Alzheimer's Disease via Upregulating GPR41 and Inhibiting ERK/JNK/NF-κB. J Agric Food Chem. 2020; 68(27):7152-7161. DOI: 10.1021/acs.jafc.0c02807. View

20.

Wang H, Yang F, Zhang S, Xin R, Sun Y . Genetic and environmental factors in Alzheimer's and Parkinson's diseases and promising therapeutic intervention via fecal microbiota transplantation. NPJ Parkinsons Dis. 2021; 7(1):70. PMC: 8357954. DOI: 10.1038/s41531-021-00213-7. View